News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

FDA Requests Label Change for Pharmion Corporation (PHRM)'s Tinzaparin



12/3/2008 7:35:27 AM

MedPage -- After reviewing results of an aborted European study involving tinzaparin (Innohep), a low molecular weight heparin product, the FDA said the drug's label should reflect increased risks for patients 70 and older.

Read at PharmaLive
Read at press release
Read at MedPageToday


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES